Kain Capital

What is Kain Capital?

Kain Capital is an investment fund specializing in early-stage investments in the BioTech, HealthTech, Fitness, Medical Devices, Hospital Services, Healthcare, Wellness, and Consumer sectors. They are focused on seeding and supporting companies through their Series A rounds, where they have the ability to drive lasting value through active collaboration and strategic guidance. Kain Capital operates with a clear investment thesis that targets companies positioned for significant growth and innovation within their respective industries.

With minimum investments starting at $100,000 and reaching up to a maximum of $5,000,000, their sweet spot resides around $1,500,000, providing a flexible range to adapt to the needs and potential of various startups.

Operating from the belief that true value is derived from partnerships, Kain Capital leverages a multidisciplinary team, including their Managing Partner Kunal Kain, Partner Steven Yecies, and their head of business development Telly Hoimes, among other vital members, to empower their portfolio companies.

Utilizing an approach that centers around Kain Analytics, they employ robust data analytics to inform their investment strategies and optimize the growth trajectories of their investments. By offering extensive operational experience and a comprehensive suite of resources, Kain Capital aims to act as a catalyst for innovators aiming to disrupt the aforementioned industries.

Their operations are based out of the iconic One World Trade Center in New York, representing a commitment to both their city and to fostering a landscape of cutting-edge solutions in healthcare and consumer markets.